ISSUE #11 ยท TUESDAY, 6 OCTOBER 2026
The Bareja Brief B logo

The Bareja Brief

Fifteen stories, five topics, under 10 minutes. Every day at 8:30 AM, in your inbox. No fluff.

Subscribe to the Brief

02Cervavac receives WHO prequalification

Serum Institute announced on October 5 that its quadrivalent HPV vaccine Cervavac has received WHO prequalification. The vaccine targets HPV types 6, 11, 16 and 18 and is indicated for girls and boys aged 9-26. Prequalification permits procurement by UN agencies.

Serum Institute of India โ†—
SUBSCRIBE

Get The Bareja Brief every morning

New readers choose five topics and confirm by email. Already subscribed? Request a private link to change your choices.